KAIBAO BIO
Kaibao Bio, founded in January 2013, is a technology research and development-driven technology company based on tumor autoantibody analysis, with lung cancer early screening kits as its main product, headquartered in Hangzhou. At present, the company's product is the only early-stage lung cancer blood screening product in the country that can be confirmed by a large sample of evidence-based medicine and has won the second prize of the National Technology Progress Award. And has completed the quotation of medical products in 19 provinces/cities, and entered the medical insurance system of 3 provinces/cities.
KAIBAO BIO
Industry:
Health Care Information Technology Medical
Founded:
2013-01-01
Status:
Active
Total Funding:
0
Investors List
Huaxia Heng Tian
Huaxia Heng Tian investment in Venture Round - Kaibao Bio
More informations about "Kaibao Bio"
Kaibao Bio - Funding, Financials, Valuation & Investors - Crunchbase
Kaibao Bio is a technology research and development-driven technology company based on tumor autoantibody analysis. ... Experience the new Crunchbase, powered by AI . Experience …See details»
Kaibao Bio | Health Care, Information Technology, Medical
Kaibao Bio, founded in January 2013, is a technology research and development-driven technology company based on tumor autoantibody analysis, with lung cancer early screening …See details»
Kaibao Bio - Drug pipelines, Patents, Clinical trials - Synapse
Jan 23, 2025 100 Translational Medicine associated with Kaibao Bio. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full …See details»
Hangzhou Kaibao Biotechnology funding & investors - Tracxn
Mar 11, 2025 Hangzhou Kaibao Biotechnology has raised a total funding of $14.2M over 1 round from 1 investor. Investor includes Hongshi Capital. Their latest funding round was of $14.2M …See details»
Kunming Kaibao Biotechnology Co., Ltd. - Drug pipelines, Patents ...
Last update 01 Nov 2024. Kunming Kaibao Biotechnology Co., Ltd. Private Company |See details»
Sichuan Kaibao Animal & Botanic Medicine Technology Co., Ltd.
Explore Sichuan Kaibao Animal & Botanic Medicine Technology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Shanghai Kaibao Pharmaceutical Co., Ltd. - synapse.zhihuiya.com
了解Shanghai Kaibao Pharmaceutical Co., Ltd. (上海凯宝药业股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的6项临床试验, 2篇新闻和16篇文献，疾病领域:肿瘤，感染，技术 …See details»
Kaibao Bio - Crunchbase
Kaibao Bio is a technology research and development-driven technology company based on tumor autoantibody analysis. New. ... Experience the new Crunchbase, powered by AI . …See details»
上海凯宝药业股份有限公司 - 百度百科
上海凯宝药业股份有限公司于2000年4月12日在海湾旅游区注册成立。拥有独立知识产权的主导产品国家二类新药痰热清注射液，于2000年12月15日被国家知识产权局专利授权，专利号 …See details»
Kaibao Bio - Updates, News, Events, Signals & Triggers - Crunchbase
Kaibao Bio is a technology research and development-driven technology company based on tumor autoantibody analysis.See details»
Kaibao Biotech, a developer of early cancer diagnosis products ...
Recently, Biotech, a developer of early cancer diagnosis products, announced the completion of a 100 million Series B financing, with investors including Capital and Bank of International.See details»
Shanghai Kaibao Pharmaceutical Co., Ltd. - Drug pipelines, Patents ...
Explore Shanghai Kaibao Pharmaceutical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, and 15 literature, Disease Domain ...See details»
BIO Statement on Resignation of Peter Marks from the FDA
1 day ago John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the …See details»
Sichuan Kaibao Animal & Botanic Medicine Technology Co., Ltd.
了解Sichuan Kaibao Animal & Botanic Medicine Technology Co., Ltd. (四川凯宝动植物药科技发展有限公司)公司的药物管线，治疗领域，技术平台，以及它的。See details»
Shanghai Kaibao Pharmaceutical CO.,Ltd - Disfold
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China. Its primary products include Tanreqing …See details»
Venture Round - Kaibao Bio - 2022-03-16 - Crunchbase
Organization Name . Kaibao Bio . Announced Date Mar 16, 2022; Funding Type ...See details»
Inner Mongolia Kaibao Pharmaceutical Co., Ltd. - Drug pipelines ...
Explore Inner Mongolia Kaibao Pharmaceutical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Kaibao Nie at University of Washington | Rate My Professors
Kaibao is an awesome professor who really cares about the subjects he teaches and the success of his students. That being said, I personally found it difficult to sit through lectures. He has an …See details»
Biologic Models - Crunchbase
Organization. Biologic Models . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. ... Kaibao …See details»
QiShen - Drug Targets, Indications, Patents - Synapse
QiShen, Initially developed by Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd., Now, its global highest R&D status is Approved, Therapeutic Areas: Nervous System …See details»